Role of gastric atrophy in mediating negative association between Helicobacter pylori infection and reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma

Gut

Volumn 57, Issue 6, 2008, Pages 721-723

  McColl, Kenneth E L ^a   Watabe, Hirotsugu ^a   Derakhshan, Mohammad H ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN; GHRELIN; PEPSINOGEN I; PEPSINOGEN II;

APPETITE; ATROPHIC GASTRITIS; BARRETT ESOPHAGUS; BODY MASS; CANCER INCIDENCE; CANCER RISK; CONFIDENCE INTERVAL; DIET; DISEASE ASSOCIATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS ULCER; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LIFESTYLE; LOWER ESOPHAGUS SPHINCTER; NOTE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; STOMACH ACID SECRETION; STOMACH ANTRUM RESECTION; STOMACH JUICE; STOMACH PROTECTION;

ADENOCARCINOMA; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; ESOPHAGITIS, PEPTIC; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PRECANCEROUS CONDITIONS;

EID: 44149114810     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2007.144774     Document Type: Note

References (26)

1. Sharma P, Sampliner RE. The rising incidence of esophageal adenocarcinoma. Adv Intern Med 2001;46:137-53.
2. Crane SJ, Locke GR 3rd, Harmsen WS, et al. The changing incidence of oesophageal and gastric adenocarcinoma by anatomic sub-site. Aliment Pharmacol Ther 2007;25:447-53.
3. van Soest EM, Dieleman PD, Siersema PD, et al. Increasing incidence of Barrett's oesophagus in the general population. Gut 2005;54:1062-6.
4. Merry AH, Schouten LJ, Goldbohm RA, et al. Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study. Gut 2007;56:1503-11.
5. Rothenbacher D, Schultze V, Jähnig P, et al. Evidence of a rapid decrease in prevalence of Helicobacter pylori infection in children of a high risk group living in Germany. Eur J Pediatr 2004;163:339-40.
6. de Martel C, Llosa AE, Farr SM, et al. Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. J Infect Dis 2005;191:761-7.
7. Clark GW. Effect of Helicobacter pylori infection in Barrett's esophagus and the genesis of esophageal adenocarcinoma. World J Surg 2003;27:994-8.
8. Raghunath A, Hungin APS, Wooff D, et al. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. BMJ 2003;326:737-9.
9. de Martel C, Liosa AE, Farr SM, et al. Helicobacter pylori infection and subsequent adenocarcinoma of the esophagus. Gastroenterology 2003;125:605-7.
10. Ye W, Held M, Lagergren J, et al. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst 2004;96:387-96.
11. Derakhshan MH, El-Omar E, Oien K, et al. Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with Helicobacter pylori. J Clin Pathol 2006;59:1293-9.
12. Goldschmiedt M, Barnett CC, Schwarz BE, et al. Effect of age on gastric acid secretion and serum gastrin concentrations in healthy men and women. Gastroenterology 1991;101:977-90.
13. Feldman M, Cryer B, McArthur KE, et al. Effects of aging and gastritis on gastric acid and pepsin secretion in humans: a prospective study. Gastroenterology 1996;110:1043-52.
14. DE Vries AC, Meijer GA, Looman CW, et al. Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in The Netherlands. Gut 2007;56:1665-70.
15. Sipponen P, Helske T, Jarvinen P, et al. Fall in the prevalence of chronic gastritis over 15 years: analysis of outpatienet series in Finland from 1977, 1985, and 1992. Gut 1994;35:1167-71.
16. Anderson LA, Murphy SJ, Johnston BT, et al. Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study. Gut 2008;57:734-9.
17. Derakhshan MH, Malekzadeh R, Watabe H, et al. Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut 2008;57:298- 305.
18. Hansen S, Vollset SE, Derakhshan MH, et al. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status. Gut 2007;56:918-25.
19. Bu X, Ma Y, Der R, et al. Body mass index is associated with Barrett esophagus and cardiac mucosal metaplasia. Dig Dis Sci 2006;51:1589-94.
20. Checchi S, Montanaro A, Pasqui L, et al. Serum ghrelin as a marker of atrophic body gastritis in patients with parietal cell antibodies. J Clin Endocrinol Metab 2007;92:4346-51.
21. Cindoruk M, Yetkin I, Deger SM, et al. Influence of H. pylori on plasma ghrelin in patients without atrophic gastritis. World J Gastroenterol 2007;13:1595-8.
22. Isomoto H, Ueno H, Saenko VA, et al. Impact of Helicobacter pylori infection on gastric and plasma ghrelin dynamics in humans. Am J Gastroenterol 2005:1711-20.
23. Owasa H, Nakazato M, Date Y, et al. Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. J Clin Endocrinol Metab 2005;90:10-6.
24. De Martel C, Haggerty TD, Corley DA, et al. Serum ghrelin levels and risk of subsequent adenocarcinoma of the esophagus. Am J Gastroenterol 2007;102:1166-72.
25. Brautet N, Plebani M, Sakarovitch C, Sipponen P, Megraud F and the Eruohepygast Study Group. Pepsinogen A, pepsinogen C and gastrin as markers of atrophic chronic gastritis in European dyspeptics. Br J Cancer 2003;88:1239-1247.
26. Genta RM, Huberman RM, Graham DY. The gastric cardia in Helicobacter pylori infection. Hum Pathol 1994;25:915-919.